In addition, CDC42 and its downstream p21-activated kinases (PAKs) are regulators of mitogen-activated protein kinase (MAPK) inhibitor resistance in BRAF mutant melanoma (Lu et al., 2017). The gene discussed is BRAF; the disease is melanoma.